Voyager Therapeutics, Inc.
MX ˙ BMV ˙ US92915B1061
SecurityMX:VYGR / Voyager Therapeutics, Inc.
InstitutionRhumbline Advisers
Latest Disclosed Ownership57,566 shares
Latest Disclosed Value $ 222,195
Rhumbline Advisers reports 2.30% decrease in ownership of VYGR / Voyager Therapeutics, Inc.

On May 12, 2026 - Rhumbline Advisers filed a 13F-HR form disclosing ownership of 57,566 shares of Voyager Therapeutics, Inc. (MX:VYGR) valued at $222,195 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 58,921 shares of Voyager Therapeutics, Inc.. This represents a change in shares of -2.30% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 57,566 -1,355 -2.30 222 -3.90 0.0002
2026-02-13 2025-12-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 58,921 -11,070 -15.82 232 -29.14 0.0002
2025-11-06 2025-09-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 69,991 1,704 2.50 327 53.77 0.0003
2025-08-12 2025-06-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 68,287 310 0.46 212 -7.42 0.0002
2025-05-29 2025-03-31 13F/A-1 VOYAGER THERAPEUTICS INC COM COM 92915B106 67,977 -3,520 -4.92 230 -43.46 0.0002
2025-04-08 2025-03-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 67,977 -3,520 230 0.0002
2025-05-29 2024-12-31 13F/A-1 VOYAGER THERAPEUTICS INC COM COM 92915B106 71,497 2,354 3.40 405 0.25 0.0004
2025-01-30 2024-12-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 71,497 2,354 405 0.0004
2024-11-12 2024-09-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 69,143 -3,318 -4.58 404 -29.49 0.0004
2024-08-01 2024-06-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 72,461 26,014 56.01 573 32.64 0.0005
2024-05-09 2024-03-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 46,447 3,711 8.68 432 20.00 0.0004
2024-02-08 2023-12-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 42,736 -304 -0.71 361 8.11 0.0004
2023-11-09 2023-09-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 43,040 1,629 3.93 334 -29.75 0.0004
2023-08-08 2023-06-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 41,411 41,411 474 0.0005
2021-08-05 2021-06-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 0 -33,868 -100.00 0 -100.00
2021-05-06 2021-03-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 33,868 -1,300 -3.70 160 -36.25 0.0002
2021-02-10 2020-12-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 35,168 3,100 9.67 251 -26.61 0.0003
2020-11-12 2020-09-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 32,068 -4,945 -13.36 342 -26.77 0.0005
2020-08-13 2020-06-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 37,013 3,456 10.30 467 52.12 0.0008
2020-05-06 2020-03-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 33,557 -1,024 -2.96 307 -36.31 0.0006
2020-02-05 2019-12-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 34,581 2,151 6.63 482 -13.62 0.0008
2019-10-23 2019-09-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 32,430 70 0.22 558 -36.66 0.0010
2019-08-14 2019-06-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 32,360 4,766 17.27 881 66.86 0.0017
2019-05-01 2019-03-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 27,594 -395 -1.41 528 100.76 0.0010
2019-01-31 2018-12-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 27,989 9,086 48.07 263 -26.54 0.0006
2018-11-07 2018-09-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 18,903 -1,355 -6.69 358 -9.60 0.0007
2018-08-06 2018-06-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 20,258 3,132 18.29 396 22.98 0.0008
2018-05-02 2018-03-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 17,126 2,493 17.04 322 32.51 0.0007
2018-02-09 2017-12-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 14,633 -1,598 -9.85 243 -27.25 0.0005
2017-11-06 2017-09-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 16,231 140 0.87 334 131.94 0.0007
2017-08-02 2017-06-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 16,091 4,144 34.69 144 -8.86 0.0003
2017-05-02 2017-03-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 11,947 499 4.36 158 8.22 0.0004
2017-01-27 2016-12-31 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 11,448 997 9.54 146 15.87 0.0004
2016-11-08 2016-09-30 13F VOYAGER THERAPEUTICS INC COM COM 92915B106 10,451 10,451 126 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.